HSR24-147: Non-Optimal Treatment in Early-Line Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Tyrosine Kinase Inhibitors (TKI): A Claims Data Analysis

Authors:
Vamsi Kota Georgia Cancer Center at Wellstar MCG Health, Augusta, GA

Search for other papers by Vamsi Kota in
Current site
Google Scholar
PubMed Close
 MD
,
David Wei Novartis Pharmaceuticals Corporation, East Hanover, NJ

Search for other papers by David Wei in
Current site
Google Scholar
PubMed Close
 PhD
,
Daisy Yang Novartis Pharmaceuticals Corporation, East Hanover, NJ

Search for other papers by Daisy Yang in
Current site
Google Scholar
PubMed Close
 PharmD
,
Hela Romdhani Groupe d’analyse, Ltée, Montréal, QC, Canada

Search for other papers by Hela Romdhani in
Current site
Google Scholar
PubMed Close
 PhD
,
Dominick Latremouille-Viau Groupe d’analyse, Ltée, Montréal, QC, Canada

Search for other papers by Dominick Latremouille-Viau in
Current site
Google Scholar
PubMed Close
 MA
,
Annie Guérin Groupe d’analyse, Ltée, Montréal, QC, Canada

Search for other papers by Annie Guérin in
Current site
Google Scholar
PubMed Close
 MSc
, and
Kejal Jadhav Novartis Pharmaceuticals Corporation, East Hanover, NJ

Search for other papers by Kejal Jadhav in
Current site
Google Scholar
PubMed Close
 MSc
Volume/Issue:
Volume 22: Issue 2.5
Online Publication Date:
05 Apr 2024
DOI:
https://doi.org/10.6004/jnccn.2023.7162
Restricted access

Corresponding Author: David Wei, PhD
Email: david-1.wei@novartis.com
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2024 by the National Comprehensive Cancer Network 2024
Article Category:
Abstract
Print Publication Date:
05 Apr 2024
Online Publication Date:
05 Apr 2024

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1006 730 61
PDF Downloads 144 0 0
EPUB Downloads 0 0 0